YANETTE BARCELO: Open Payments
NPI 1407252885 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 26 payments from 12 companies in 2025. Trend: 2023 $779 · 2024 $508 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $174 |
| Regeneron Healthcare Solutions, Inc. | 5 | $136 |
| Arcutis Biotherapeutics, Inc. | 2 | $48 |
| Incyte Corporation | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| LEO Pharma Inc. | 1 | $24 |
| KYOWA KIRIN, INC. | 1 | $24 |
| Journey Medical Corporation | 1 | $23 |
| Amgen Inc. | 1 | $21 |
Products named: DUPIXENT, Zoryve, OPZELURA, Rhapsido, BLU-U, ANZUPGO, POTELIGEO, LIBTAYO.
Industry payments across FL — which companies pay providers there.
